SCANCELL HOLDINGS PLC ORD 0.1P chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A£ (N/A)
Beta N/A
Market capitalization 130.93M
Operating cash flow N/A
ESG Scores unknown

Company description

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. The company's product candidates include SCIB1, which is in phase II clinical trial for the treatment of metastatic melanoma; SCIB2 for the treatment of non-small cell lung cancer; and Modi-1 that is in phase I/II clinical trials for the treatment of head and neck, triple negative breast, ovarian, and renal cancers. It also develops Modi-2, which targets homocitrullinated cancer antigens. In addition, the company develops SCOV1 and SCOV2 COVIDITY, a prophylactic DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio19.46
Working Capital-0.37
Return On Equity-0.79
Debt To Equity0.78
Fixed Asset Ratio2.09
Fixed Interest Cover-5.91

Financial data

Financial Statements

Cashflow Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Change To Liabilities 509k -164k 1.05M 51k
Total Cashflows From Investing Activities 12k -13k -741k -1.26M
Net Borrowings -27k -27k 23.35M -391k
Total Cash From Financing Activities 1.28M 3.8M 46.08M -928k
Change To Operating Activities
Issuance Of Stock 1.36M 3.88M 24.14M
Net Income -5.63M -5.51M -15.48M -2.06M
Change In Cash -5.74M -985k 37.53M -12.38M
Effect Of Exchange Rate
Total Cash From Operating Activities -7.03M -4.77M -7.8M -10.19M
Depreciation 21k 43k 249k 740k
Change To Account Receivables -580k 307k -597k 321k
Other Cashflows From Financing Activities -83k -50k -1.41M -537k
Change To Netincome -1.36M 548k 6.98M -9.24M
Capital Expenditures -3k -27k -744k -1.27M

Income Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Research Development 4.15M 4.67M 6.41M 9.48M
Income Before Tax -6.71M -6.77M -16.8M -3.77M
Net Income -5.63M -5.51M -15.48M -2.06M
Selling General Administrative 2.58M 2.12M 3.35M 4.79M
Gross Profit
Ebit -6.73M -6.78M -9.75M -13.3M
Operating Income -6.73M -6.78M -9.75M -13.3M
Interest Expense -1.65M -1.65M -1.65M -2.88M
Income Tax Expense -1.09M -1.26M -1.33M -1.7M
Total Revenue
Cost Of Revenue
Total Other Income ExpenseNet 15k 14k -7.05M 9.53M
Net Income From Continuing Ops -5.63M -5.51M -15.48M -2.06M
Net Income Applicable To Common Shares -5.63M -5.51M -15.48M -2.06M

Balance Sheet Statement 2019-04-30 2020-04-30 2021-04-30 2022-04-30
Total Liabilities 1.21M 1.17M 29.57M 20.41M
Total Stockholder Equity 9.34M 7.65M 19.48M 18.11M
Other Current Liabilities 58k 61k 64k
Total Assets 10.54M 8.82M 49.06M 38.52M
Common Stock 388k 465k 815k 815k
Other Current Assets
Retained Earnings -26.07M -31.58M -47.05M -49.12M
Treasury Stock 382k 372k 705k 1.4M
Cash 4.56M 3.58M 41.11M 28.73M
Total Current Liabilities 1.21M 1.09M 2.29M 2.14M
Other Stockholder Equity 382k 372k 705k 1.4M
Property, Plant, and Equipment 58k 195k 975k 2.74M
Total Current Assets 7.07M 5.21M 44.67M 32.36M
Net Tangible Assets 5.92M 4.23M 16.07M 14.7M
Net Receivables 2.02M 1.33M 2.84M 3.64M
Accounts Payable 716k 395k 821k 2.14M


Insider Transactions

Here are the insider transactions of stock shares related to SCANCELL HOLDINGS PLC ORD 0.1P:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Calculus Capital LtdD2022-09-234.89M
Barclays Bank PlcD2022-03-30
Vulpes Life Science FundBought at price 0.16 per share.D2022-03-02250k
Vulpes Life Science FundBought at price 0.26 per share.D2021-11-02200k
Vulpes Life Science FundBought at price 0.26 per share.D2021-10-29100k
Holloway (Clifford Michael)D2021-10-28
Goodfellow (Richard Morley)D2021-10-28
Adams (Sally Elizabeth)D2021-10-28
Chiplin (John C)D2021-10-28
Calculus Capital LtdD2021-10-27
Redmile Group, L.L.C.D2021-10-27
Vulpes Life Science FundD2021-10-27
Durrant (Lindy Gillian)Sold at price 0.28 per share.D2021-09-094.46M
Durrant (Lindy Gillian)Sold at price 0.29 per share.D2021-09-092.38M
Calculus Capital LtdD2021-08-10
Redmile Group, L.L.C.D2021-08-10
Vulpes Life Science FundD2021-08-10
Vulpes Life Science FundBought at price 0.28 per share.D2021-07-29200k
Vulpes Life Science FundBought at price 0.27 per share.D2021-06-04400k
Holloway (Clifford Michael)D2021-04-30
Vulpes Life Science FundD2021-04-30
Durrant (Lindy Gillian)D2021-04-30
Goodfellow (Richard Morley)D2021-04-30
Adams (Sally Elizabeth)D2021-04-30
Chiplin (John C)D2021-04-30
Vulpes Life Science FundBought at price 0.28 per share.D2021-04-29400k
Calculus Capital LtdD2021-03-101.01M
Vulpes Life Science FundSold at price 0.38 per share.D2021-02-18400k
Vulpes Life Science FundSold at price 0.36 per share.D2021-02-171.25M
Vulpes Life Science FundSold at price 0.33 per share.D2021-02-16400k
Vulpes Life Science FundBought at price 0.15 per share.D2020-12-14750k
Vulpes Life Science FundBought at price 0.14 per share.D2020-12-11248.82k
Holloway (Clifford Michael)Bought at price 0.15 per share.D2020-11-24100k
Vulpes Life Science FundBought at price 0.14 per share.D2020-11-12100k
Vulpes Life Science FundBought at price 0.14 per share.D2020-11-11100k
Vulpes Life Science FundBought at price 0.16 per share.D2020-11-10300k
Vulpes Life Science FundBought at price 0.17 per share.D2020-11-063.67M
Redmile Group, L.L.C.D2020-11-0253.33M
Vulpes Life Science FundD2020-11-0216.39M

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to SCANCELL HOLDINGS PLC ORD 0.1P. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on SCANCELL HOLDINGS PLC ORD 0.1P

Here is the result of two systematic investment strategies applied to SCANCELL HOLDINGS PLC ORD 0.1P. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the equity curve of the two systematic investment strategies applied to SCANCELL HOLDINGS PLC ORD 0.1P:

SCANCELL HOLDINGS PLC ORD 0.1P automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 127.29% on the backtest period.

Performance at glance

Performance

127.29 %

Latent gain

2542.56 £

Invested capital

1997.44 £

Annualized return

30.9 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on SCANCELL HOLDINGS PLC ORD 0.1P

This is the result of two momentum investment strategies applied to SCANCELL HOLDINGS PLC ORD 0.1P. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows all the entries opened by the momentum investment system on SCANCELL HOLDINGS PLC ORD 0.1P:

SCANCELL HOLDINGS PLC ORD 0.1P momentum entries
  • The first momentum investment strategy would give 118.41% of return on SCANCELL HOLDINGS PLC ORD 0.1P. That represents 4705.79£ of latent gain with 3974.21£ of employed capital.
  • The second momentum investment strategy would give 123.61% of return on SCANCELL HOLDINGS PLC ORD 0.1P. That represents 4311.77£ of latent gain with 3488.23£ of employed capital.
Performance at glance (1Q Momentum)

Performance

118.41 %

Latent gain

4705.79 £

Invested capital

3974.21 £

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

123.61 %

Latent gain

4311.77 £

Invested capital

3488.23 £

Annualized return

33.96 %

Momentum equity curve on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the equity curve of the two momentum strategies applied to SCANCELL HOLDINGS PLC ORD 0.1P:

SCANCELL HOLDINGS PLC ORD 0.1P momentum equity

Note: the dividends potentially given by SCANCELL HOLDINGS PLC ORD 0.1P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the employed capital evolution of the two momentum strategies on SCANCELL HOLDINGS PLC ORD 0.1P since the beginning:

SCANCELL HOLDINGS PLC ORD 0.1P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250£, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000£.


Buy the dip strategy result on SCANCELL HOLDINGS PLC ORD 0.1P

Buy the dip entry openings on SCANCELL HOLDINGS PLC ORD 0.1P

SCANCELL HOLDINGS PLC ORD 0.1P

The performance achieved by the robo-advisor on SCANCELL HOLDINGS PLC ORD 0.1P is 0%. That represents 0.0$ of latent gain with 0.0£ of employed capital. The following chart shows SCANCELL HOLDINGS PLC ORD 0.1P stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of SCANCELL HOLDINGS PLC ORD 0.1P, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 £

Invested capital

0.0 £

Annualized return

0.0 %

Equity curve of the strategy applied to SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the result of the investment strategy applied to SCANCELL HOLDINGS PLC ORD 0.1P:

SCANCELL HOLDINGS PLC ORD 0.1P

Note: the dividends potentially given by SCANCELL HOLDINGS PLC ORD 0.1P are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the employed capital evolution since the beginning of the investment strategy on SCANCELL HOLDINGS PLC ORD 0.1P:

SCANCELL HOLDINGS PLC ORD 0.1P

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on SCANCELL HOLDINGS PLC ORD 0.1P

In this section, I will compare the three previous investment strategies applied to SCANCELL HOLDINGS PLC ORD 0.1P.

Equity curve comparison on SCANCELL HOLDINGS PLC ORD 0.1P

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

SCANCELL HOLDINGS PLC ORD 0.1P investment strategy comparison

Employed capital comparison on SCANCELL HOLDINGS PLC ORD 0.1P

SCANCELL HOLDINGS PLC ORD 0.1P investment comparison

Performance comparison on SCANCELL HOLDINGS PLC ORD 0.1P

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 127.29% 2542.56£ 1997.44£ 30.9%
Momentum 1 quarter 118.41% 4705.79£ 3974.21£ 30.52%
Momentum 2 quarters 123.61% 4311.77£ 3488.23£ 33.96%
Non-directional 0% 0.0£ 0.0£ 0.0%
Annualized return comparison

Automatic investment

30.9 %

Momentum 1Q

33.96 %

Momentum 2Q

33.96 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with SCANCELL HOLDINGS PLC ORD 0.1P:

Positive correlations

Most correlated stocks this year

  • SCANCELL HOLDINGS PLC ORD 0.1P

  • Most correlated stocks last 3 months

  • SCANCELL HOLDINGS PLC ORD 0.1P
  • LIGHTSPEED POS INC

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months

  • JIASHILI GP

  • Note: The algorithm computes the probability of correlation between SCANCELL HOLDINGS PLC ORD 0.1P and the other stocks. There may be false positives or some missing correlated stocks. If the price of SCANCELL HOLDINGS PLC ORD 0.1P does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name SCANCELL HOLDINGS PLC ORD 0.1P
    Country United Kingdom
    City Oxford
    Address Unit 202 Bellhouse Building
    Phone 44 18 6558 2066
    Website www.scancell.co.uk
    FullTime employees
    Industry Biotechnology
    Sector Healthcare
    Exchange XLON
    Ticker SCLP.XLON
    Market www.londonstockexchange.com

    SCANCELL HOLDINGS PLC ORD 0.1P ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown